Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
This study will measure the impact of treatment with Viagra on the depressive symptoms and
quality of life in men with erectile dysfunction who have untreated depressive symptoms
meeting the DSM-IV criteria for dysthymia or depression not otherwise specified (NOS),
including minor depressive symptoms but excluding any form of psychotic disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.